• 1
    Plotz PH, Rider LG, Targoff IN, Raben N, O'Hanlon TP, Miller FW. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy. Ann Intern Med 1995; 122: 71524.
  • 2
    Pearson CM. Polymyositis and dermatomyositis. In: KoopmanWJ, editor. Arthritis and allied conditions. Baltimore: Williams & Wilkins; 1997. p. 74261.
  • 3
    Hirakata M, Mimori T, Akizuki M, Craft J, Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 1992; 35: 44956.
  • 4
    Targoff IN, Johnson AE, Miller FW. Antibody to signal recognition particle in polymyositis. Arthritis Rheum 1990; 33: 136170.
  • 5
    Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 1985; 28: 796803.
  • 6
    Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 2002; 46: 62636.
  • 7
    Tokiyama K, Tagawa H, Yokota E, Nagasawa K, Kusaba T, Tsuda Y, et al. Two cases of amyopathic dermatomyositis with fatal rapidly progressive interstitial pneumonitis. Ryumachi 1990; 30: 20411. In Japanese.
  • 8
    Targoff IN, Trieu EP, Sontheimer RD. Autoantibodies to 155 kD and Se antigens in patients with clinically-amyopathic dermatomyositis [abstract]. Arthritis Rheum 2000; 43 Suppl 9: S194.
  • 9
    Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 1999; 162: 231520.
  • 10
    Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc Natl Acad Sci U S A 1979; 76: 43504.
  • 11
    Lane RJ, Emslie-Smith A, Mosquera IE, Hudgson P. Clinical, biochemical and histological responses to treatment in polymyositis: a prospective study. J R Soc Med 1989; 82: 3338.
  • 12
    Targoff IN. Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002; 28: 85990.
  • 13
    Euwer RL, Sontheimer RD. Amyopathic dermatomyositis: a review. J Invest Dermatol 1993; 100: 124S7S.
  • 14
    Oddis CV, Fertig N, Goel A, Espada G, Confalone Gregorian M, Maldonado Cocco JA, et al. Clinical and serological characterization of the anti-MJ antibody in childhood myositis [abstract]. Arthritis Rheum 1997; 40 Suppl 9: S139.
  • 15
    Espada G, Confalone Gregorian M, Ortiz Z, Fertig N, Londino AV, Oddis CV, et al. Serum autoantibodies in juvenile idiopathic inflammatory myopathies (IIM) in a cohort of Argentine patients [abstract]. Arthritis Rheum 1997; 40 Suppl 9: S140.